Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing

The Journal of Clinical Endocrinology and Metabolism
Andrew R HoffmanT002 Study Group

Abstract

To determine whether an individualized dose titration regimen (ID) for adult GH replacement therapy would have similar efficacy and better tolerability than a fixed body weight-based dosing regimen (FD), 387 adults with GH deficiency were randomized to FD (n = 200) or ID (n = 187) for 32 wk. In FD, subjects received sequentially 4, 8, and 12 microg/kg.d GH. ID was started at 0.2 mg/d and increased by 0.2-mg/d increments, based on clinical and serum IGF-I responses, to a maximum of 0.8 mg/d. Increases (mean +/- sd) in serum IGF-I were similar in both groups (FD, 110.2 +/- 87.8 vs. ID, 99.6 +/- 77.7 microg/liter, P = 0.20) despite higher final GH doses in FD (0.70 +/- 0.32 vs. 0.54 +/- 0.22 mg/d, P < 0.001). Favorable changes in several efficacy measures were observed with no significant differences between the FD and ID groups: lean body mass increased; health-related quality of life improved; and abdominal fat mass, hip circumference, sum of skinfolds, and total and low-density lipoprotein cholesterol decreased. The decrease in fat mass was greater with FD than ID for men (-2.7 +/- 2.7 kg vs. -1.8 +/- 2.5 kg, P = 0.04) but not for women (-2.1 +/- 2.4 vs. -2.0 +/- 3.8 kg). The change in waist circumference was greater with FD th...Continue Reading

Citations

Feb 1, 2007·Pituitary·Christoph J Auernhammer, George Vlotides
Apr 6, 2007·Pituitary·Claire E HighamPeter J Trainer
Feb 27, 2013·Nature Reviews. Endocrinology·Johannes D Veldhuis
May 18, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ho ChoBruce E Kimmel
Dec 10, 2002·Annual Review of Medicine·David E Cummings, George R Merriam
Nov 16, 2012·European Journal of Endocrinology·Valentina GascoGianluca Aimaretti
Jul 5, 2005·European Journal of Endocrinology·Kazuo ChiharaAndrea F Attanasio
Aug 18, 2009·European Journal of Endocrinology·A Mukherjee, S M Shalet
Nov 11, 2008·Journal of Endocrinological Investigation·A GiustinaUNKNOWN European Neuroendocrine Association
Apr 9, 2008·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kazuo ChiharaHitoshi Kohno
Feb 20, 2008·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·K ChiharaA Shimatsu
Aug 29, 2007·Pediatric Clinics of North America·Sergio R R Buzzini
Jul 26, 2005·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Andrew R Hoffman
Apr 26, 2006·The Journal of Clinical Endocrinology and Metabolism·Mark E MolitchPatricia A Stephens
Apr 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Fatih TanriverdiFahrettin Kelestimur
Nov 13, 2013·The Cochrane Database of Systematic Reviews·Florence GillaizeauPierre Durieux
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Maya BarakeNicholas A Tritos
Sep 10, 2008·Expert Opinion on Pharmacotherapy·Torben LaursenJens Sandahl Christiansen
Jul 10, 2007·The Journal of Clinical Endocrinology and Metabolism·Jeffrey Baron
Mar 16, 2007·The Journal of Clinical Endocrinology and Metabolism·Pinchas CohenUNKNOWN American Norditropin Study Group
Jul 1, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·David R Clemmons
Mar 17, 2010·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·David M CookUNKNOWN American Association of Clinical Endocrinologists
Nov 26, 2019·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Kevin C J YuenAndrew R Hoffman
Oct 8, 2020·Reviews in Endocrine & Metabolic Disorders·Cesar Luiz Boguszewski
Dec 15, 2020·The Journal of Clinical Endocrinology and Metabolism·Rasmus Juul KildemoesRune Viig Overgaard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.